tolmetin has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
tolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, C | 1 |
| Fulda, GJ | 1 |
| Castellano, J | 1 |
1 other study available for tolmetin and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Lithium-induced nephrogenic diabetes insipidus treated with intravenous ketorolac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Humans; | 1995 |